2026 Lipid Guidelines Beyond Statins:  Non- Statin Agents to Manage Dyslipidemias - Poll - MDSpire

2026 Lipid Guidelines Beyond Statins:  Non- Statin Agents to Manage Dyslipidemias

Dr. Talreja  discusses the 2026 standard of care for treatment of dyslipidemia with new screening guidelines and advanced therapy options.

  • June 12, 2026

Share

Original Source(s)

2026 Lipid Guidelines Beyond Statins:  Non- Statin Agents to Manage Dyslipidemias

  • June 12, 2026

Related Content

Managing remnant cholesterol: role of fenofibrate–statin therapy in reducing triglyceride-rich lipoproteins

Machine-learning prediction of impaired outcome in diabetic patients undergoing non-cardiac surgery

Association Between Metabolic Clusters and Microbial Age in High-Risk Populations for Diabetes and Their Potential Impact on Cardiovascular Disease Risk: Cross-Sectional Observational Study